Arkolith/Insider Trading/EW/Form 4

Ullem Scott B.

CVP, Chief Financial OfficerEdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)13K$59.26$770K52K
May 5, 2026Tax withholding(F)11K$82.91$923K41K
May 3, 2026Tax withholding(F)620$83.98$52K39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)13K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-004969) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML